Tag: amniotic membrane market share

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Amniotic Membrane Market Growth From $2.08 Billion In 2026 To $3.15 Billion By 2030 At A CAGR Of 10.9%

The market for amniotic membrane has experienced significant expansion recently. Projections indicate a rise from $1.88 billion in 2025 to $2.09 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.8%. This past growth was fueled by several key factors, including the burgeoning field of regenerative medicine research, escalating demands for surgical wound management solutions, increased utilization within ophthalmology, the presence of advanced tissue preservation technologies, and the growing trend of biological treatments administered in hospital settings.

The amniotic membrane market is projected for substantial expansion, reaching an estimated value of $3.15 billion by 2030 with a projected compound annual growth rate of 10.9%. This anticipated surge is fueled by several key factors, including a heightened need for sophisticated wound healing treatments, a greater incorporation into less invasive surgical techniques, the proliferation of ambulatory surgical centers, a stronger emphasis on therapeutic approaches utilizing biological agents, and clearer regulatory frameworks for products derived from tissues. Over the forecast horizon, significant trends expected to shape the market include a growing utilization of amniotic membranes in regenerative medicine, increased application in eye surgeries, broader use in managing wounds, a rising preference for cryopreserved forms, and an intensified commitment to ensuring the safety of biological products.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8830&type=smp

#Amniotic Membrane Market Growth Factors: Which Forces Are Supporting Market Expansion?

A surge in organ and tissue transplantation procedures is anticipated to fuel the expansion of the amniotic membrane market. Transplantation, a process where tissues or organs are surgically moved from a donor to a recipient, frequently incorporates amniotic membranes to aid in surgical interventions and reconstructive efforts, thereby fostering tissue regeneration and patient recovery. This heightened transplantation activity is a direct result of increased public awareness regarding organ donation, advancements in surgical methodologies, and more sophisticated donor-recipient matching algorithms. Amniotic membrane allografts contribute to the healing process post-transplantation by offering a biologically active extracellular matrix along with regulatory proteins that encourage tissue rebuilding. Illustrating this trend, the Organ Procurement and Transplantation Network (OPTN) reported that in 2023, the United States performed a total of 46,632 organ transplants, an 8.7 percent increase from the previous year, with a further 3.6 percent rise to 41,119 deceased-donor transplants observed in the first part of 2024, demonstrating sustained growth in transplant procedures. Consequently, the escalating volume of transplant activities is a key driver for the amniotic membrane market.

The escalating incidence of long-term illnesses is poised to stimulate further growth within the amniotic membrane market. Chronic diseases are defined as conditions that persist for a minimum of three months and have the potential to worsen over time. The amniotic membrane, owing to its inherent anti-inflammatory and regenerative characteristics, proves exceptionally useful in managing these persistent health issues, mitigating associated complications, and addressing tissue deterioration. The broad applicability of the amniotic membrane across different medical fields addresses the pressing need for efficient therapeutic interventions required for chronic conditions. For example, projections from the World Health Organization in February 2024 indicated that by 2050, approximately 35 million new cancer diagnoses are expected, representing a significant 77% jump from the estimated 20 million cases recorded in 2022. Accordingly, the growing prevalence of chronic diseases is a significant factor contributing to the expansion of the amniotic membrane market.

Amniotic Membrane Market Segmentation And Category Breakdown

The amniotic membrane market covered in this report is segmented –

1) By Product: Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane

2) By Application: Surgical Wounds, Ophthalmology, Other Applications

3) By End-Use: Hospitals, Ambulatory Surgical Centers (ASCs), Other End-Users

Subsegments:

1) By Cryopreserved Amniotic Membrane: Dehydrated Cryopreserved Amniotic Membrane, Fresh Cryopreserved Amniotic Membrane

2) By Lyophilization Amniotic Membrane: Sterilized Lyophilized Amniotic Membrane, Non-Sterilized Lyophilized Amniotic Membrane

Amniotic Membrane Market Industry Trends: What Changes Are Reshaping Demand?

The foremost entities within the amniotic membrane sector are dedicating their efforts to the creation of sophisticated allografts, aiming to enhance patient well-being and achieve superior clinical results. Amniotic membrane allografts, which are sourced from the innermost placental layer, serve a crucial role in addressing ocular and surgical tissue damage by furnishing a natural extracellular matrix along with growth factors that foster accelerated healing. As an illustration, in December 2024, BioTissue, a prominent American biotechnology firm, introduced CAM360 AmnioGraft (CAM360 AG), a shelf-stable, cryopreserved amniotic membrane product that notably lacks a ring, designed for the management of dry eye conditions ranging from mild to moderate, and for halting the progression of early-stage neurotrophic keratitis. This innovative product bestows upon eye care practitioners a range of adaptable application methods, encompassing placement beneath a bandage contact lens or in conjunction with a collagen shield, and importantly, facilitates prompt symptom alleviation typically within a 48-hour timeframe. Furthermore, CAM360 AG not only broadens the spectrum of therapeutic possibilities but also streamlines inventory oversight for healthcare facilities, thus underscoring how advancements such as CAM360 AG are instrumental in propelling the expansion of the amniotic membrane market.

Amniotic Membrane Market Competitive Analysis Of Major Industry Participants

Major companies operating in the amniotic membrane market are MiMedx Group Inc, Organogenesis Holdings Inc, Amnio Technology LLC, Applied Biologics LLC, Human Regenerative Technologies LLC, Skye Biologics Inc, Amniox Medical Inc, Bio-Tissue Inc, TissueTech Inc, Osiris Therapeutics Inc, VIVEX Biologics Inc, Merakris Therapeutics Inc, Celularity Inc, BioLab Sciences, LifeCell International Pvt. Ltd., FzioMed Inc, Corza Ophthalmology, Integra LifeSciences Co, Smith & Nephew, RTI Surgical

Access The Complete Amniotic Membrane Market Report:

https://www.thebusinessresearchcompany.com/report/amniotic-membrane-global-market-report

Amniotic Membrane Market Regional Analysis: Which Region Leads By Revenue?

North Americawas the largest region in the amniotic membrane market share in 2025.Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic membrane market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Amniotic Membrane Market Growth From $2.08 Billion In 2026 To $3.15 Billion By 2030 At A CAGR Of 10.9%

The market for amniotic membrane has experienced significant expansion recently. Projections indicate a rise from $1.88 billion in 2025 to $2.09 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.8%. This past growth was fueled by several key factors, including the burgeoning field of regenerative medicine research, escalating demands for surgical wound management solutions, increased utilization within ophthalmology, the presence of advanced tissue preservation technologies, and the growing trend of biological treatments administered in hospital settings.

The amniotic membrane market is projected for substantial expansion, reaching an estimated value of $3.15 billion by 2030 with a projected compound annual growth rate of 10.9%. This anticipated surge is fueled by several key factors, including a heightened need for sophisticated wound healing treatments, a greater incorporation into less invasive surgical techniques, the proliferation of ambulatory surgical centers, a stronger emphasis on therapeutic approaches utilizing biological agents, and clearer regulatory frameworks for products derived from tissues. Over the forecast horizon, significant trends expected to shape the market include a growing utilization of amniotic membranes in regenerative medicine, increased application in eye surgeries, broader use in managing wounds, a rising preference for cryopreserved forms, and an intensified commitment to ensuring the safety of biological products.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8830&type=smp

#Amniotic Membrane Market Growth Factors: Which Forces Are Supporting Market Expansion?

A surge in organ and tissue transplantation procedures is anticipated to fuel the expansion of the amniotic membrane market. Transplantation, a process where tissues or organs are surgically moved from a donor to a recipient, frequently incorporates amniotic membranes to aid in surgical interventions and reconstructive efforts, thereby fostering tissue regeneration and patient recovery. This heightened transplantation activity is a direct result of increased public awareness regarding organ donation, advancements in surgical methodologies, and more sophisticated donor-recipient matching algorithms. Amniotic membrane allografts contribute to the healing process post-transplantation by offering a biologically active extracellular matrix along with regulatory proteins that encourage tissue rebuilding. Illustrating this trend, the Organ Procurement and Transplantation Network (OPTN) reported that in 2023, the United States performed a total of 46,632 organ transplants, an 8.7 percent increase from the previous year, with a further 3.6 percent rise to 41,119 deceased-donor transplants observed in the first part of 2024, demonstrating sustained growth in transplant procedures. Consequently, the escalating volume of transplant activities is a key driver for the amniotic membrane market.

The escalating incidence of long-term illnesses is poised to stimulate further growth within the amniotic membrane market. Chronic diseases are defined as conditions that persist for a minimum of three months and have the potential to worsen over time. The amniotic membrane, owing to its inherent anti-inflammatory and regenerative characteristics, proves exceptionally useful in managing these persistent health issues, mitigating associated complications, and addressing tissue deterioration. The broad applicability of the amniotic membrane across different medical fields addresses the pressing need for efficient therapeutic interventions required for chronic conditions. For example, projections from the World Health Organization in February 2024 indicated that by 2050, approximately 35 million new cancer diagnoses are expected, representing a significant 77% jump from the estimated 20 million cases recorded in 2022. Accordingly, the growing prevalence of chronic diseases is a significant factor contributing to the expansion of the amniotic membrane market.

Amniotic Membrane Market Segmentation And Category Breakdown

The amniotic membrane market covered in this report is segmented –

1) By Product: Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane

2) By Application: Surgical Wounds, Ophthalmology, Other Applications

3) By End-Use: Hospitals, Ambulatory Surgical Centers (ASCs), Other End-Users

Subsegments:

1) By Cryopreserved Amniotic Membrane: Dehydrated Cryopreserved Amniotic Membrane, Fresh Cryopreserved Amniotic Membrane

2) By Lyophilization Amniotic Membrane: Sterilized Lyophilized Amniotic Membrane, Non-Sterilized Lyophilized Amniotic Membrane

Amniotic Membrane Market Industry Trends: What Changes Are Reshaping Demand?

The foremost entities within the amniotic membrane sector are dedicating their efforts to the creation of sophisticated allografts, aiming to enhance patient well-being and achieve superior clinical results. Amniotic membrane allografts, which are sourced from the innermost placental layer, serve a crucial role in addressing ocular and surgical tissue damage by furnishing a natural extracellular matrix along with growth factors that foster accelerated healing. As an illustration, in December 2024, BioTissue, a prominent American biotechnology firm, introduced CAM360 AmnioGraft (CAM360 AG), a shelf-stable, cryopreserved amniotic membrane product that notably lacks a ring, designed for the management of dry eye conditions ranging from mild to moderate, and for halting the progression of early-stage neurotrophic keratitis. This innovative product bestows upon eye care practitioners a range of adaptable application methods, encompassing placement beneath a bandage contact lens or in conjunction with a collagen shield, and importantly, facilitates prompt symptom alleviation typically within a 48-hour timeframe. Furthermore, CAM360 AG not only broadens the spectrum of therapeutic possibilities but also streamlines inventory oversight for healthcare facilities, thus underscoring how advancements such as CAM360 AG are instrumental in propelling the expansion of the amniotic membrane market.

Amniotic Membrane Market Competitive Analysis Of Major Industry Participants

Major companies operating in the amniotic membrane market are MiMedx Group Inc, Organogenesis Holdings Inc, Amnio Technology LLC, Applied Biologics LLC, Human Regenerative Technologies LLC, Skye Biologics Inc, Amniox Medical Inc, Bio-Tissue Inc, TissueTech Inc, Osiris Therapeutics Inc, VIVEX Biologics Inc, Merakris Therapeutics Inc, Celularity Inc, BioLab Sciences, LifeCell International Pvt. Ltd., FzioMed Inc, Corza Ophthalmology, Integra LifeSciences Co, Smith & Nephew, RTI Surgical

Access The Complete Amniotic Membrane Market Report:

https://www.thebusinessresearchcompany.com/report/amniotic-membrane-global-market-report

Amniotic Membrane Market Regional Analysis: Which Region Leads By Revenue?

North Americawas the largest region in the amniotic membrane market share in 2025.Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic membrane market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Amniotic Membrane Market Growth From $2.08 Billion In 2026 To $3.15 Billion By 2030 At A CAGR Of 10.9%

The market for amniotic membrane has experienced significant expansion recently. Projections indicate a rise from $1.88 billion in 2025 to $2.09 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.8%. This past growth was fueled by several key factors, including the burgeoning field of regenerative medicine research, escalating demands for surgical wound management solutions, increased utilization within ophthalmology, the presence of advanced tissue preservation technologies, and the growing trend of biological treatments administered in hospital settings.

The amniotic membrane market is projected for substantial expansion, reaching an estimated value of $3.15 billion by 2030 with a projected compound annual growth rate of 10.9%. This anticipated surge is fueled by several key factors, including a heightened need for sophisticated wound healing treatments, a greater incorporation into less invasive surgical techniques, the proliferation of ambulatory surgical centers, a stronger emphasis on therapeutic approaches utilizing biological agents, and clearer regulatory frameworks for products derived from tissues. Over the forecast horizon, significant trends expected to shape the market include a growing utilization of amniotic membranes in regenerative medicine, increased application in eye surgeries, broader use in managing wounds, a rising preference for cryopreserved forms, and an intensified commitment to ensuring the safety of biological products.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8830&type=smp

#Amniotic Membrane Market Growth Factors: Which Forces Are Supporting Market Expansion?

A surge in organ and tissue transplantation procedures is anticipated to fuel the expansion of the amniotic membrane market. Transplantation, a process where tissues or organs are surgically moved from a donor to a recipient, frequently incorporates amniotic membranes to aid in surgical interventions and reconstructive efforts, thereby fostering tissue regeneration and patient recovery. This heightened transplantation activity is a direct result of increased public awareness regarding organ donation, advancements in surgical methodologies, and more sophisticated donor-recipient matching algorithms. Amniotic membrane allografts contribute to the healing process post-transplantation by offering a biologically active extracellular matrix along with regulatory proteins that encourage tissue rebuilding. Illustrating this trend, the Organ Procurement and Transplantation Network (OPTN) reported that in 2023, the United States performed a total of 46,632 organ transplants, an 8.7 percent increase from the previous year, with a further 3.6 percent rise to 41,119 deceased-donor transplants observed in the first part of 2024, demonstrating sustained growth in transplant procedures. Consequently, the escalating volume of transplant activities is a key driver for the amniotic membrane market.

The escalating incidence of long-term illnesses is poised to stimulate further growth within the amniotic membrane market. Chronic diseases are defined as conditions that persist for a minimum of three months and have the potential to worsen over time. The amniotic membrane, owing to its inherent anti-inflammatory and regenerative characteristics, proves exceptionally useful in managing these persistent health issues, mitigating associated complications, and addressing tissue deterioration. The broad applicability of the amniotic membrane across different medical fields addresses the pressing need for efficient therapeutic interventions required for chronic conditions. For example, projections from the World Health Organization in February 2024 indicated that by 2050, approximately 35 million new cancer diagnoses are expected, representing a significant 77% jump from the estimated 20 million cases recorded in 2022. Accordingly, the growing prevalence of chronic diseases is a significant factor contributing to the expansion of the amniotic membrane market.

Amniotic Membrane Market Segmentation And Category Breakdown

The amniotic membrane market covered in this report is segmented –

1) By Product: Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane

2) By Application: Surgical Wounds, Ophthalmology, Other Applications

3) By End-Use: Hospitals, Ambulatory Surgical Centers (ASCs), Other End-Users

Subsegments:

1) By Cryopreserved Amniotic Membrane: Dehydrated Cryopreserved Amniotic Membrane, Fresh Cryopreserved Amniotic Membrane

2) By Lyophilization Amniotic Membrane: Sterilized Lyophilized Amniotic Membrane, Non-Sterilized Lyophilized Amniotic Membrane

Amniotic Membrane Market Industry Trends: What Changes Are Reshaping Demand?

The foremost entities within the amniotic membrane sector are dedicating their efforts to the creation of sophisticated allografts, aiming to enhance patient well-being and achieve superior clinical results. Amniotic membrane allografts, which are sourced from the innermost placental layer, serve a crucial role in addressing ocular and surgical tissue damage by furnishing a natural extracellular matrix along with growth factors that foster accelerated healing. As an illustration, in December 2024, BioTissue, a prominent American biotechnology firm, introduced CAM360 AmnioGraft (CAM360 AG), a shelf-stable, cryopreserved amniotic membrane product that notably lacks a ring, designed for the management of dry eye conditions ranging from mild to moderate, and for halting the progression of early-stage neurotrophic keratitis. This innovative product bestows upon eye care practitioners a range of adaptable application methods, encompassing placement beneath a bandage contact lens or in conjunction with a collagen shield, and importantly, facilitates prompt symptom alleviation typically within a 48-hour timeframe. Furthermore, CAM360 AG not only broadens the spectrum of therapeutic possibilities but also streamlines inventory oversight for healthcare facilities, thus underscoring how advancements such as CAM360 AG are instrumental in propelling the expansion of the amniotic membrane market.

Amniotic Membrane Market Competitive Analysis Of Major Industry Participants

Major companies operating in the amniotic membrane market are MiMedx Group Inc, Organogenesis Holdings Inc, Amnio Technology LLC, Applied Biologics LLC, Human Regenerative Technologies LLC, Skye Biologics Inc, Amniox Medical Inc, Bio-Tissue Inc, TissueTech Inc, Osiris Therapeutics Inc, VIVEX Biologics Inc, Merakris Therapeutics Inc, Celularity Inc, BioLab Sciences, LifeCell International Pvt. Ltd., FzioMed Inc, Corza Ophthalmology, Integra LifeSciences Co, Smith & Nephew, RTI Surgical

Access The Complete Amniotic Membrane Market Report:

https://www.thebusinessresearchcompany.com/report/amniotic-membrane-global-market-report

Amniotic Membrane Market Regional Analysis: Which Region Leads By Revenue?

North Americawas the largest region in the amniotic membrane market share in 2025.Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic membrane market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Amniotic Membrane Market Progress Between 2026 And 2030?

The amniotic membrane market has seen rapid expansion in recent years. Its valuation is expected to rise from $1.88 billion in 2025 to $2.09 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. This historical growth can be linked to the expansion of regenerative medicine research, the increasing necessity for surgical wound management, its adoption in ophthalmology practices, the availability of tissue preservation technologies, and the growing use of hospital-based biologic treatments.

The amniotic membrane market is anticipated to experience substantial growth in the upcoming years, projected to reach $3.15 billion by 2030, advancing at a compound annual growth rate (CAGR) of 10.9%. This expansion during the forecast period is fueled by an escalating need for sophisticated wound healing treatments, increasing deployment in minimally invasive surgical procedures, the expansion of outpatient surgical options, a heightened focus on therapies derived from biologics, and improved regulatory clarity concerning tissue-based offerings. Prominent developments expected in this period include the expanding application of amniotic membranes in regenerative medicine, growing adoption in ophthalmic operations, a broader spectrum of wound care uses, an increased appetite for cryopreserved items, and a strengthened emphasis on the safety protocols for biological products.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/amniotic-membrane-global-market-report

What Key Factors Are Affecting The Amniotic Membrane Market Demand?

The amniotic membrane market is anticipated to expand due to increasing transplant procedures. These procedures, involving the surgical transfer of tissues or organs, frequently incorporate amniotic membranes in reconstructive and surgical operations to facilitate tissue repair and enhance patient recovery. The rise in transplant operations is fueled by greater organ donation awareness, advancements in surgical methods, and more effective donor-recipient matching. Amniotic membrane allografts aid post-transplant healing by offering a biologically active extracellular matrix and vital regulatory proteins that encourage tissue regeneration. For example, data from January 2024 by the Organ Procurement and Transplantation Network (OPTN), a US-based entity overseeing the national organ transplant system, showed that the United States achieved 46,632 total organ transplants in 2023, an 8.7 percent increase from 2022. Additionally, deceased-donor transplants reached 41,119 in 2024, indicating a 3.6 percent rise over 2023, driven by continuous annual growth. Consequently, the uptick in transplant activity is a significant factor propelling the amniotic membrane market’s expansion.

Amniotic Membrane Market Driver: Rising Prevalence Of Chronic Diseases To Drive Market Growth

What Are The Different Segment Types In The Amniotic Membrane Market Segment Breakdown?

The amniotic membrane market covered in this report is segmented –

1) By Product: Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane

2) By Application: Surgical Wounds, Ophthalmology, Other Applications

3) By End-Use: Hospitals, Ambulatory Surgical Centers (ASCs), Other End-Users

Subsegments:

1) By Cryopreserved Amniotic Membrane: Dehydrated Cryopreserved Amniotic Membrane, Fresh Cryopreserved Amniotic Membrane

2) By Lyophilization Amniotic Membrane: Sterilized Lyophilized Amniotic Membrane, Non-Sterilized Lyophilized Amniotic Membrane

What Trends Are Influencing Changes In The Amniotic Membrane Market?

Leading companies in the amniotic membrane market are dedicated to developing advanced allografts aimed at enhancing patient care and improving clinical outcomes. Amniotic membrane allografts are tissues sourced from the innermost layer of the placenta, utilized in treating ocular and surgical wounds by supplying a natural extracellular matrix and growth factors that facilitate healing. For instance, in December 2024, BioTissue, a US-based biotechnology firm, unveiled CAM360 AmnioGraft (CAM360 AG), a ringless, shelf-stable cryopreserved amniotic membrane intended for the treatment of mild to moderate dry eye and early-stage neurotrophic keratitis. This product provides eye care professionals with flexible application options, including its use under a bandage contact lens or with a collagen shield, and offers rapid symptom relief within 48 hours. CAM360 AG not only broadens treatment choices but also simplifies inventory management for clinics. Consequently, innovations like CAM360 AG are stimulating growth in the amniotic membrane market.

Who Are The Well-Known Companies In The Amniotic Membrane Market?

Major companies operating in the amniotic membrane market are MiMedx Group Inc, Organogenesis Holdings Inc, Amnio Technology LLC, Applied Biologics LLC, Human Regenerative Technologies LLC, Skye Biologics Inc, Amniox Medical Inc, Bio-Tissue Inc, TissueTech Inc, Osiris Therapeutics Inc, VIVEX Biologics Inc, Merakris Therapeutics Inc, Celularity Inc, BioLab Sciences, LifeCell International Pvt. Ltd., FzioMed Inc, Corza Ophthalmology, Integra LifeSciences Co, Smith & Nephew, RTI Surgical

Get The Full Amniotic Membrane Market Report:

https://www.thebusinessresearchcompany.com/report/amniotic-membrane-global-market-report

Which Region Has The Greatest Market Share In The Amniotic Membrane Market?

North America was the largest region in the amniotic membrane market share in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic membrane market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Amniotic Membrane Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/amniotic-membrane-global-market-report

Browse Through More Reports Similar to the Global Amniotic Membrane Market 2026, By The Business Research Company

Breathable Membranes Market Report 2026

https://www.thebusinessresearchcompany.com/report/breathable-membranes-global-market-report

Amniotic Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/amniotic-products-global-market-report

Specialty Breathable Membranes Market Report 2026

https://www.thebusinessresearchcompany.com/report/specialty-breathable-membranes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Amniotic Membrane Market Progress Between 2026 And 2030?

The amniotic membrane market has seen rapid expansion in recent years. Its valuation is expected to rise from $1.88 billion in 2025 to $2.09 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. This historical growth can be linked to the expansion of regenerative medicine research, the increasing necessity for surgical wound management, its adoption in ophthalmology practices, the availability of tissue preservation technologies, and the growing use of hospital-based biologic treatments.

The amniotic membrane market is anticipated to experience substantial growth in the upcoming years, projected to reach $3.15 billion by 2030, advancing at a compound annual growth rate (CAGR) of 10.9%. This expansion during the forecast period is fueled by an escalating need for sophisticated wound healing treatments, increasing deployment in minimally invasive surgical procedures, the expansion of outpatient surgical options, a heightened focus on therapies derived from biologics, and improved regulatory clarity concerning tissue-based offerings. Prominent developments expected in this period include the expanding application of amniotic membranes in regenerative medicine, growing adoption in ophthalmic operations, a broader spectrum of wound care uses, an increased appetite for cryopreserved items, and a strengthened emphasis on the safety protocols for biological products.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/amniotic-membrane-global-market-report

What Key Factors Are Affecting The Amniotic Membrane Market Demand?

The amniotic membrane market is anticipated to expand due to increasing transplant procedures. These procedures, involving the surgical transfer of tissues or organs, frequently incorporate amniotic membranes in reconstructive and surgical operations to facilitate tissue repair and enhance patient recovery. The rise in transplant operations is fueled by greater organ donation awareness, advancements in surgical methods, and more effective donor-recipient matching. Amniotic membrane allografts aid post-transplant healing by offering a biologically active extracellular matrix and vital regulatory proteins that encourage tissue regeneration. For example, data from January 2024 by the Organ Procurement and Transplantation Network (OPTN), a US-based entity overseeing the national organ transplant system, showed that the United States achieved 46,632 total organ transplants in 2023, an 8.7 percent increase from 2022. Additionally, deceased-donor transplants reached 41,119 in 2024, indicating a 3.6 percent rise over 2023, driven by continuous annual growth. Consequently, the uptick in transplant activity is a significant factor propelling the amniotic membrane market’s expansion.

Amniotic Membrane Market Driver: Rising Prevalence Of Chronic Diseases To Drive Market Growth

What Are The Different Segment Types In The Amniotic Membrane Market Segment Breakdown?

The amniotic membrane market covered in this report is segmented –

1) By Product: Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane

2) By Application: Surgical Wounds, Ophthalmology, Other Applications

3) By End-Use: Hospitals, Ambulatory Surgical Centers (ASCs), Other End-Users

Subsegments:

1) By Cryopreserved Amniotic Membrane: Dehydrated Cryopreserved Amniotic Membrane, Fresh Cryopreserved Amniotic Membrane

2) By Lyophilization Amniotic Membrane: Sterilized Lyophilized Amniotic Membrane, Non-Sterilized Lyophilized Amniotic Membrane

What Trends Are Influencing Changes In The Amniotic Membrane Market?

Leading companies in the amniotic membrane market are dedicated to developing advanced allografts aimed at enhancing patient care and improving clinical outcomes. Amniotic membrane allografts are tissues sourced from the innermost layer of the placenta, utilized in treating ocular and surgical wounds by supplying a natural extracellular matrix and growth factors that facilitate healing. For instance, in December 2024, BioTissue, a US-based biotechnology firm, unveiled CAM360 AmnioGraft (CAM360 AG), a ringless, shelf-stable cryopreserved amniotic membrane intended for the treatment of mild to moderate dry eye and early-stage neurotrophic keratitis. This product provides eye care professionals with flexible application options, including its use under a bandage contact lens or with a collagen shield, and offers rapid symptom relief within 48 hours. CAM360 AG not only broadens treatment choices but also simplifies inventory management for clinics. Consequently, innovations like CAM360 AG are stimulating growth in the amniotic membrane market.

Who Are The Well-Known Companies In The Amniotic Membrane Market?

Major companies operating in the amniotic membrane market are MiMedx Group Inc, Organogenesis Holdings Inc, Amnio Technology LLC, Applied Biologics LLC, Human Regenerative Technologies LLC, Skye Biologics Inc, Amniox Medical Inc, Bio-Tissue Inc, TissueTech Inc, Osiris Therapeutics Inc, VIVEX Biologics Inc, Merakris Therapeutics Inc, Celularity Inc, BioLab Sciences, LifeCell International Pvt. Ltd., FzioMed Inc, Corza Ophthalmology, Integra LifeSciences Co, Smith & Nephew, RTI Surgical

Get The Full Amniotic Membrane Market Report:

https://www.thebusinessresearchcompany.com/report/amniotic-membrane-global-market-report

Which Region Has The Greatest Market Share In The Amniotic Membrane Market?

North America was the largest region in the amniotic membrane market share in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic membrane market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Amniotic Membrane Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/amniotic-membrane-global-market-report

Browse Through More Reports Similar to the Global Amniotic Membrane Market 2026, By The Business Research Company

Breathable Membranes Market Report 2026

https://www.thebusinessresearchcompany.com/report/breathable-membranes-global-market-report

Amniotic Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/amniotic-products-global-market-report

Specialty Breathable Membranes Market Report 2026

https://www.thebusinessresearchcompany.com/report/specialty-breathable-membranes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Amniotic Membrane Market Progress Between 2026 And 2030?

The amniotic membrane market has seen rapid expansion in recent years. Its valuation is expected to rise from $1.88 billion in 2025 to $2.09 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. This historical growth can be linked to the expansion of regenerative medicine research, the increasing necessity for surgical wound management, its adoption in ophthalmology practices, the availability of tissue preservation technologies, and the growing use of hospital-based biologic treatments.

The amniotic membrane market is anticipated to experience substantial growth in the upcoming years, projected to reach $3.15 billion by 2030, advancing at a compound annual growth rate (CAGR) of 10.9%. This expansion during the forecast period is fueled by an escalating need for sophisticated wound healing treatments, increasing deployment in minimally invasive surgical procedures, the expansion of outpatient surgical options, a heightened focus on therapies derived from biologics, and improved regulatory clarity concerning tissue-based offerings. Prominent developments expected in this period include the expanding application of amniotic membranes in regenerative medicine, growing adoption in ophthalmic operations, a broader spectrum of wound care uses, an increased appetite for cryopreserved items, and a strengthened emphasis on the safety protocols for biological products.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/amniotic-membrane-global-market-report

What Key Factors Are Affecting The Amniotic Membrane Market Demand?

The amniotic membrane market is anticipated to expand due to increasing transplant procedures. These procedures, involving the surgical transfer of tissues or organs, frequently incorporate amniotic membranes in reconstructive and surgical operations to facilitate tissue repair and enhance patient recovery. The rise in transplant operations is fueled by greater organ donation awareness, advancements in surgical methods, and more effective donor-recipient matching. Amniotic membrane allografts aid post-transplant healing by offering a biologically active extracellular matrix and vital regulatory proteins that encourage tissue regeneration. For example, data from January 2024 by the Organ Procurement and Transplantation Network (OPTN), a US-based entity overseeing the national organ transplant system, showed that the United States achieved 46,632 total organ transplants in 2023, an 8.7 percent increase from 2022. Additionally, deceased-donor transplants reached 41,119 in 2024, indicating a 3.6 percent rise over 2023, driven by continuous annual growth. Consequently, the uptick in transplant activity is a significant factor propelling the amniotic membrane market’s expansion.

Amniotic Membrane Market Driver: Rising Prevalence Of Chronic Diseases To Drive Market Growth

What Are The Different Segment Types In The Amniotic Membrane Market Segment Breakdown?

The amniotic membrane market covered in this report is segmented –

1) By Product: Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane

2) By Application: Surgical Wounds, Ophthalmology, Other Applications

3) By End-Use: Hospitals, Ambulatory Surgical Centers (ASCs), Other End-Users

Subsegments:

1) By Cryopreserved Amniotic Membrane: Dehydrated Cryopreserved Amniotic Membrane, Fresh Cryopreserved Amniotic Membrane

2) By Lyophilization Amniotic Membrane: Sterilized Lyophilized Amniotic Membrane, Non-Sterilized Lyophilized Amniotic Membrane

What Trends Are Influencing Changes In The Amniotic Membrane Market?

Leading companies in the amniotic membrane market are dedicated to developing advanced allografts aimed at enhancing patient care and improving clinical outcomes. Amniotic membrane allografts are tissues sourced from the innermost layer of the placenta, utilized in treating ocular and surgical wounds by supplying a natural extracellular matrix and growth factors that facilitate healing. For instance, in December 2024, BioTissue, a US-based biotechnology firm, unveiled CAM360 AmnioGraft (CAM360 AG), a ringless, shelf-stable cryopreserved amniotic membrane intended for the treatment of mild to moderate dry eye and early-stage neurotrophic keratitis. This product provides eye care professionals with flexible application options, including its use under a bandage contact lens or with a collagen shield, and offers rapid symptom relief within 48 hours. CAM360 AG not only broadens treatment choices but also simplifies inventory management for clinics. Consequently, innovations like CAM360 AG are stimulating growth in the amniotic membrane market.

Who Are The Well-Known Companies In The Amniotic Membrane Market?

Major companies operating in the amniotic membrane market are MiMedx Group Inc, Organogenesis Holdings Inc, Amnio Technology LLC, Applied Biologics LLC, Human Regenerative Technologies LLC, Skye Biologics Inc, Amniox Medical Inc, Bio-Tissue Inc, TissueTech Inc, Osiris Therapeutics Inc, VIVEX Biologics Inc, Merakris Therapeutics Inc, Celularity Inc, BioLab Sciences, LifeCell International Pvt. Ltd., FzioMed Inc, Corza Ophthalmology, Integra LifeSciences Co, Smith & Nephew, RTI Surgical

Get The Full Amniotic Membrane Market Report:

https://www.thebusinessresearchcompany.com/report/amniotic-membrane-global-market-report

Which Region Has The Greatest Market Share In The Amniotic Membrane Market?

North America was the largest region in the amniotic membrane market share in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic membrane market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Amniotic Membrane Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/amniotic-membrane-global-market-report

Browse Through More Reports Similar to the Global Amniotic Membrane Market 2026, By The Business Research Company

Breathable Membranes Market Report 2026

https://www.thebusinessresearchcompany.com/report/breathable-membranes-global-market-report

Amniotic Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/amniotic-products-global-market-report

Specialty Breathable Membranes Market Report 2026

https://www.thebusinessresearchcompany.com/report/specialty-breathable-membranes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Amniotic Membrane Market Projected To Become By 2030 Based On Its 2026 Valuation?

The amniotic membrane market has experienced substantial expansion in recent times. This market is projected to expand from $1.88 billion in 2025 to $2.09 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.8%. Historically, this growth was driven by several factors, including the increased scope of regenerative medicine research, the rising demand for surgical wound care, its integration into ophthalmology, the accessibility of advanced tissue preservation techniques, and the proliferation of hospital-administered biologic therapies.

The amniotic membrane market is projected for significant expansion over the coming years, with its size expected to reach $3.15 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.9%. This anticipated growth during the forecast period is primarily fueled by an increasing demand for advanced wound healing solutions, a rising adoption in minimally invasive surgical procedures, the expansion of outpatient surgical procedures, a growing focus on biologic-based therapies, and increasing regulatory clarity for tissue-based products. Key trends identified for the forecast period encompass the expanding use of amniotic membranes in regenerative therapies, their increasing utilization in ophthalmic procedures, broadening applications within wound care, a surging demand for cryopreserved products, and an enhanced emphasis on biologic safety standards.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8830&type=smp

What Primary Drivers Are Shaping The Development Of The Amniotic Membrane Market?

The expansion of transplant operations is anticipated to boost the amniotic membrane market in the future. Transplantation, which involves the surgical transfer of tissues or organs from a donor to a recipient, frequently employs amniotic membranes in surgical and reconstructive procedures to aid tissue repair and recovery. The surge in transplant procedures is attributed to factors like heightened organ donation awareness, advancements in surgical techniques, and improved processes for donor-recipient matching. Amniotic membrane allografts contribute to post-transplant healing by supplying a biologically active extracellular matrix and regulatory proteins that encourage tissue regeneration. As an illustration, in January 2024, data from the Organ Procurement and Transplantation Network (OPTN), a US-based entity managing the national organ transplant system, revealed that the United States achieved 46,632 total organ transplants in 2023, marking an 8.7 percent increase from 2022, and 41,119 deceased-donor transplants in 2024, representing a further 3.6 percent rise over 2023, driven by consistent annual increases. Consequently, the escalating transplant activity is propelling the growth of the amniotic membrane market. The growing occurrence of chronic diseases is expected to stimulate the expansion of the amniotic membrane market moving forward. A chronic disease is defined as an illness persisting for three months or longer that can worsen over time. The distinct characteristics of amniotic membranes, such as their anti-inflammatory and regenerative capabilities, make them invaluable for managing chronic conditions, mitigating complications, and addressing tissue damage. The extensive applicability of amniotic membranes allows their use across various medical fields, thereby meeting the demand for effective therapeutic interventions related to chronic diseases. For example, in February 2024, the World Health Organization, a Switzerland-based United Nations agency, projected that new cancer cases would exceed 35 million by 2050, signifying a 77% increase compared to the estimated 20 million cases in 2022. Thus, the increasing prevalence of chronic diseases is driving the growth of the amniotic membrane market.

What Segment Groups Are Identified Within The Amniotic Membrane Market?

The amniotic membrane market covered in this report is segmented –

1) By Product: Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane

2) By Application: Surgical Wounds, Ophthalmology, Other Applications

3) By End-Use: Hospitals, Ambulatory Surgical Centers (ASCs), Other End-Users

Subsegments:

1) By Cryopreserved Amniotic Membrane: Dehydrated Cryopreserved Amniotic Membrane, Fresh Cryopreserved Amniotic Membrane

2) By Lyophilization Amniotic Membrane: Sterilized Lyophilized Amniotic Membrane, Non-Sterilized Lyophilized Amniotic Membrane

What Trends Are Advancing Progress In The Amniotic Membrane Market?

Companies operating in the amniotic membrane market are prioritizing the development of advanced allografts to elevate patient care and clinical outcomes. Amniotic membrane allografts are tissues derived from the placenta’s innermost layer, employed in treating ocular and surgical wounds by supplying a natural extracellular matrix and growth factors to foster healing. For instance, in December 2024, BioTissue, a US-based biotechnology company, launched CAM360 AmnioGraft (CAM360 AG), a ringless, shelf-stable cryopreserved amniotic membrane intended for the treatment of mild to moderate dry eye and early-stage neurotrophic keratitis. This product offers eye care professionals versatile application options, including its use under a bandage contact lens or with a collagen shield, and facilitates rapid symptom relief within 48 hours. CAM360 AG expands treatment choices while also simplifying inventory management for clinics. Therefore, innovations such as CAM360 AG are significantly driving growth in the amniotic membrane market.

Which Companies Hold Significant Positions In The Amniotic Membrane Market?

Major companies operating in the amniotic membrane market are MiMedx Group Inc, Organogenesis Holdings Inc, Amnio Technology LLC, Applied Biologics LLC, Human Regenerative Technologies LLC, Skye Biologics Inc, Amniox Medical Inc, Bio-Tissue Inc, TissueTech Inc, Osiris Therapeutics Inc, VIVEX Biologics Inc, Merakris Therapeutics Inc, Celularity Inc, BioLab Sciences, LifeCell International Pvt. Ltd., FzioMed Inc, Corza Ophthalmology, Integra LifeSciences Co, Smith & Nephew, RTI Surgical

Read the full amniotic membrane market report here:

https://www.thebusinessresearchcompany.com/report/amniotic-membrane-global-market-report

How Does The Amniotic Membrane Market Perform Across Major Global Regions?

North America was the largest region in the amniotic membrane market share in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic membrane market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Amniotic Membrane Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8830&type=smp

Browse Through More Reports Similar to the Global Amniotic Membrane Market 2026, By The Business Research Company

amniotic products global market report

https://www.thebusinessresearchcompany.com/report/amniotic-products-global-market-report

specialty breathable membranes global market report

https://www.thebusinessresearchcompany.com/report/specialty-breathable-membranes-global-market-report

breathable membranes global market report

https://www.thebusinessresearchcompany.com/report/breathable-membranes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model